| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,756 |
1,376 |
$99K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
421 |
326 |
$33K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
537 |
492 |
$26K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
347 |
249 |
$10K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,051 |
831 |
$7K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
564 |
414 |
$5K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
255 |
204 |
$3K |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
291 |
221 |
$2K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
14 |
14 |
$577.28 |
| 93000 |
|
31 |
27 |
$353.18 |
| 82947 |
|
105 |
89 |
$296.79 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
107 |
91 |
$132.35 |
| 81002 |
|
27 |
24 |
$62.61 |
| 96127 |
|
15 |
15 |
$3.27 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
25 |
13 |
$0.00 |